Dr Craig Moskowitz speaks with ecancertv at BSH 2016 about talks given at the conference, and patient therapies in trial and practice.

Speaking on a range of therapies from pre-transplant PET imaging to combination therapies such as brentuximab-vedotin and incorporation of PD-1 checkpoint inhibitors, Dr Moskowitz describes the changing field of haemato-oncology.

Looking to the near future, he comments on the potential of chemotherapy-free treatment from the perspective of patients, physicians and healthcare providers.